EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking of Chiral Drug Enantiomers With Different Bioactivities

Ekaterina V Semenova iD, Ekaterina V Belova iD, Alexey V Sulimov iD, Vladimir B Sulimov iD

Chirality · 2024-09 · 36 (9)

DOI: 10.1002/chir.23712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chirality, online erschienen am 28.08.2024. Verfasst von Ekaterina V Semenova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dimonta, Ltd, Moscow, Russia. Hauptthemen laut MEDLINE: Molecular Docking Simulation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chirality has an important role in the drug design because enantiomers may exhibit different bioactivity when interacting with macromolecules of a living organism. In our previous work, based on the analysis of a set of 100 chiral drugs, a relationship was established between the sign of chirality of enantiomers and their bioactivity. To understand the reasons for the observed patterns of chiral specificity of drug enantiomers, the interaction of 10 enantiomeric pairs of chiral drugs with the corresponding target proteins has been considered using molecular docking and further postprocessing by quantum chemistry methods. The data obtained confirm that the energetic aspect of the interaction between opposite enantiomers and target protein affects the enantiomer biological activity. In addition, the results show that molecular docking is able to distinguish between bioactive and inactive/less active enantiomers, although many docking programs are not accurate enough to distinguish a weak inhibitor from a strong one.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationStereoisomerismPharmaceutical PreparationsProteins

Stichwörter der Autor:innen

chiralitydockingenantiomersmolecular modelingquantum chemistry calculation

Substanzen

Pharmaceutical PreparationsProteins

Autor:innen und Institutionen

  • Dimonta, Ltd, Moscow, Russia.
  • Research Computing Center, Lomonosov Moscow State University, Moscow, Russia.
  • Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia.

ORCID-Profile: Ekaterina V Semenova, Ekaterina V Belova, Alexey V Sulimov, Vladimir B Sulimov

Förderung

  • Russian Science Foundation

Zitieren

APA

Semenova, E. V., Belova, E. V., Sulimov, A. V., & Sulimov, V. B. (2024). Molecular Docking of Chiral Drug Enantiomers With Different Bioactivities. Chirality, 36(9). https://doi.org/10.1002/chir.23712

Vancouver

Semenova EV, Belova EV, Sulimov AV, Sulimov VB. Molecular Docking of Chiral Drug Enantiomers With Different Bioactivities. Chirality. 2024;36(9). doi:10.1002/chir.23712

BibTeX
@article{Semenova2024,
  author = {Semenova, Ekaterina V and Belova, Ekaterina V and Sulimov, Alexey V and Sulimov, Vladimir B},
  title = {Molecular Docking of Chiral Drug Enantiomers With Different Bioactivities},
  journal = {Chirality},
  year = {2024},
  volume = {36},
  number = {9},
  doi = {10.1002/chir.23712}
}
Kostenlos starten →